Kimball Johnson
Internal Medicine · Atlanta, GANPI 1568464063
Payments from drug & device makers
Across 3,330 payments — averaging $15,360 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Modernatx, Inc.$15M
- E.r. Squibb & Sons, L.L.C.$9.7M
- AbbVie$6M
- Eli Lilly$3M
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2.8M
- Vanda Pharmaceuticals Inc.$2.7M
- plus $12M from 34 others
Across 38 payments — averaging $1547.53 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$33K
- Eli Lilly$20K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$2K
- Astellas Pharma Global Development$2K
- Takeda Pharmaceuticals U.S.A., Inc.$2K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$51,149,074 in reported general payments places this provider in the 95th percentile of 3,311 internal medicine providers in Georgia.
Other internal medicine in Atlanta
- Robert Springer IiiAtlanta$5.3M
- Paulina Rebolledo EsteinouAtlanta$2.1M
- Courtney SheltonAtlanta$1.2M
- Melanie ThompsonAtlanta$1.1M
- Tracey HenryAtlanta$305K
- David WatsonAtlanta$286K
- Priscilla Igho-PemuAtlanta$269K
- Robert HerreraAtlanta$261K
- Syed RahmanAtlanta$211K
- Scott ParryAtlanta$162K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.